Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Dan Morehead of Pantera Capital Talks Treasury Yields, Inflation, and Crypto Outlook
-
Bitcoin Stays Flat At $29.5K After Federal Reserve Hikes Interest Rate To 22-Year Highs
-
Extreme Networks Climbs 6%; Launches Outdoor Wi-Fi 6E Access Point
-
Pundit Who Predicted Bitcoin's Plunge To $20k Lowers Bet To $12,000
-
Fastenal Slips As Sales Miss Expectations